Risk factors for extended-spectrum β-lactamaseproducing escherichia coli infection in hospitalized patients

Yoshiaki Iked, Takayoshi Mamiya, Hideki Nishiyama, Takenao Koseki, Akihiro Mouri, Toshitaka Nabeshima

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The incidence of nosocomial infection caused by extended-spectrum b-lactamase (ESBL)-producing bacteria is increasing worldwide. Infections caused by ESBL producers have been associated with severe adverse clinical outcomes that have led to increased mortality, prolonged hospitalization, and rising medical costs. To avoid such adverse events and ineffective treatment, an appropriate use of drugs for infectious diseases is needed. To suppress the emergence and spread of drug-resistant bacteria in hospitals, it is important to be vigilant about ESBL-producing Escherichia coli (E. coli). In this study, we examined and compared seven items in a blood test between patients with ESBL-producing E. coli and non- ESBL-producing E. coli among febrile patients. We examined the levels of serum albumin, hemoglobin, and C-reactive protein (CRP), and the numbers of leucocytes, neutrophils, lymphocytes, and platelets in blood on the day of admission, the screening day during hospitalization, and the day immediately before discharge from the hospital. There were no significant differences in clinical background characteristics between the two groups of patients. In patients with invasive infections caused by ESBL-producing E. coli, serum albumin levels and the number of lymphocytes were significantly lower than those in patients not infected with ESBL producers. These values recovered to their baseline levels on the day of hospital discharge. This retrospective study suggests that serum albumin levels and the number of lymphocytes may serve as risk factors for infection by ESBL-producing E. coli, thereby supporting the appropriate use of antimicrobials in hospitals.

Original languageEnglish
Pages (from-to)105-114
Number of pages10
JournalNagoya Journal of Medical Science
Volume74
Issue number1-2
Publication statusPublished - 01-12-2012
Externally publishedYes

Fingerprint

Escherichia coli Infections
Escherichia coli
Serum Albumin
Lymphocyte Count
Hospitalization
Infection
Hemoglobin C
Bacteria
Hematologic Tests
Cross Infection
Leukocyte Count
Pharmaceutical Preparations
C-Reactive Protein
Communicable Diseases
Neutrophils
Fever
Blood Platelets
Retrospective Studies
Lymphocytes
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Iked, Yoshiaki ; Mamiya, Takayoshi ; Nishiyama, Hideki ; Koseki, Takenao ; Mouri, Akihiro ; Nabeshima, Toshitaka. / Risk factors for extended-spectrum β-lactamaseproducing escherichia coli infection in hospitalized patients. In: Nagoya Journal of Medical Science. 2012 ; Vol. 74, No. 1-2. pp. 105-114.
@article{6b61154d649e43b196fafd988e08cc81,
title = "Risk factors for extended-spectrum β-lactamaseproducing escherichia coli infection in hospitalized patients",
abstract = "The incidence of nosocomial infection caused by extended-spectrum b-lactamase (ESBL)-producing bacteria is increasing worldwide. Infections caused by ESBL producers have been associated with severe adverse clinical outcomes that have led to increased mortality, prolonged hospitalization, and rising medical costs. To avoid such adverse events and ineffective treatment, an appropriate use of drugs for infectious diseases is needed. To suppress the emergence and spread of drug-resistant bacteria in hospitals, it is important to be vigilant about ESBL-producing Escherichia coli (E. coli). In this study, we examined and compared seven items in a blood test between patients with ESBL-producing E. coli and non- ESBL-producing E. coli among febrile patients. We examined the levels of serum albumin, hemoglobin, and C-reactive protein (CRP), and the numbers of leucocytes, neutrophils, lymphocytes, and platelets in blood on the day of admission, the screening day during hospitalization, and the day immediately before discharge from the hospital. There were no significant differences in clinical background characteristics between the two groups of patients. In patients with invasive infections caused by ESBL-producing E. coli, serum albumin levels and the number of lymphocytes were significantly lower than those in patients not infected with ESBL producers. These values recovered to their baseline levels on the day of hospital discharge. This retrospective study suggests that serum albumin levels and the number of lymphocytes may serve as risk factors for infection by ESBL-producing E. coli, thereby supporting the appropriate use of antimicrobials in hospitals.",
author = "Yoshiaki Iked and Takayoshi Mamiya and Hideki Nishiyama and Takenao Koseki and Akihiro Mouri and Toshitaka Nabeshima",
year = "2012",
month = "12",
day = "1",
language = "English",
volume = "74",
pages = "105--114",
journal = "Nagoya Journal of Medical Science",
issn = "0027-7622",
publisher = "Nagoya University, School of Medicine",
number = "1-2",

}

Risk factors for extended-spectrum β-lactamaseproducing escherichia coli infection in hospitalized patients. / Iked, Yoshiaki; Mamiya, Takayoshi; Nishiyama, Hideki; Koseki, Takenao; Mouri, Akihiro; Nabeshima, Toshitaka.

In: Nagoya Journal of Medical Science, Vol. 74, No. 1-2, 01.12.2012, p. 105-114.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk factors for extended-spectrum β-lactamaseproducing escherichia coli infection in hospitalized patients

AU - Iked, Yoshiaki

AU - Mamiya, Takayoshi

AU - Nishiyama, Hideki

AU - Koseki, Takenao

AU - Mouri, Akihiro

AU - Nabeshima, Toshitaka

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The incidence of nosocomial infection caused by extended-spectrum b-lactamase (ESBL)-producing bacteria is increasing worldwide. Infections caused by ESBL producers have been associated with severe adverse clinical outcomes that have led to increased mortality, prolonged hospitalization, and rising medical costs. To avoid such adverse events and ineffective treatment, an appropriate use of drugs for infectious diseases is needed. To suppress the emergence and spread of drug-resistant bacteria in hospitals, it is important to be vigilant about ESBL-producing Escherichia coli (E. coli). In this study, we examined and compared seven items in a blood test between patients with ESBL-producing E. coli and non- ESBL-producing E. coli among febrile patients. We examined the levels of serum albumin, hemoglobin, and C-reactive protein (CRP), and the numbers of leucocytes, neutrophils, lymphocytes, and platelets in blood on the day of admission, the screening day during hospitalization, and the day immediately before discharge from the hospital. There were no significant differences in clinical background characteristics between the two groups of patients. In patients with invasive infections caused by ESBL-producing E. coli, serum albumin levels and the number of lymphocytes were significantly lower than those in patients not infected with ESBL producers. These values recovered to their baseline levels on the day of hospital discharge. This retrospective study suggests that serum albumin levels and the number of lymphocytes may serve as risk factors for infection by ESBL-producing E. coli, thereby supporting the appropriate use of antimicrobials in hospitals.

AB - The incidence of nosocomial infection caused by extended-spectrum b-lactamase (ESBL)-producing bacteria is increasing worldwide. Infections caused by ESBL producers have been associated with severe adverse clinical outcomes that have led to increased mortality, prolonged hospitalization, and rising medical costs. To avoid such adverse events and ineffective treatment, an appropriate use of drugs for infectious diseases is needed. To suppress the emergence and spread of drug-resistant bacteria in hospitals, it is important to be vigilant about ESBL-producing Escherichia coli (E. coli). In this study, we examined and compared seven items in a blood test between patients with ESBL-producing E. coli and non- ESBL-producing E. coli among febrile patients. We examined the levels of serum albumin, hemoglobin, and C-reactive protein (CRP), and the numbers of leucocytes, neutrophils, lymphocytes, and platelets in blood on the day of admission, the screening day during hospitalization, and the day immediately before discharge from the hospital. There were no significant differences in clinical background characteristics between the two groups of patients. In patients with invasive infections caused by ESBL-producing E. coli, serum albumin levels and the number of lymphocytes were significantly lower than those in patients not infected with ESBL producers. These values recovered to their baseline levels on the day of hospital discharge. This retrospective study suggests that serum albumin levels and the number of lymphocytes may serve as risk factors for infection by ESBL-producing E. coli, thereby supporting the appropriate use of antimicrobials in hospitals.

UR - http://www.scopus.com/inward/record.url?scp=84860639131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860639131&partnerID=8YFLogxK

M3 - Article

C2 - 22515116

AN - SCOPUS:84860639131

VL - 74

SP - 105

EP - 114

JO - Nagoya Journal of Medical Science

JF - Nagoya Journal of Medical Science

SN - 0027-7622

IS - 1-2

ER -